Recombinant human parathyroid hormone (1-34) increases bone mineral density in men with both idiopathic and hypogonadal osteoporosis.

被引：0
|
作者：
Orwoll, ES
Scheele, WH
Clancy, AD
Adami, S
Syversen, U
Kaufman, JM
Diez-Perez, A
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1958
引用
收藏
页码：S379 / S379
页数：1
相关论文
共 50 条
  • [31] Growth hormone increases bone mineral content in postmenopausal osteoporosis.
    Landin-Wilhelmsen, KLL
    Nilsson, A
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S222 - S222
  • [32] HUMAN PARATHYROID HORMONE(1-34) INCREASES BONE-FORMATION AND STRENGTH OF CORTICAL BONE IN AGED RATS
    EJERSTED, C
    ANDREASSEN, TT
    NILSSON, MHL
    OXLUND, H
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 130 (02) : 201 - 207
  • [33] Teriparatide (hPTH-[1-34]) - A recombinant human parathyroid hormone fragment with anabolic actions for the treatment of osteoporosis
    Ashworth, LE
    [J]. FORMULARY, 2002, 37 (03) : 129 - +
  • [34] Efficacy and safety of recombinant human parathyroid hormone (1-34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis
    Deng, Jing
    Feng, Zhengping
    Li, Yue
    Pan, Tingting
    Li, Qifu
    Zhao, Changhong
    [J]. MEDICINE, 2018, 97 (47)
  • [35] Nasal administration of a novel recombinant human parathyroid hormone (1-34) analog for the treatment of osteoporosis of ovariectomized rats
    Shi Xiaoming
    Wang Chunxiao
    Zhuang Zhihua
    Lu Jingning
    Liu Jingjing
    Wu Jie
    Cao Rongyue
    Li Taiming
    [J]. REGULATORY PEPTIDES, 2011, 170 (1-3) : 52 - 56
  • [36] Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber - A dose-response study
    Skripitz, R
    Andreassen, TT
    Aspenberg, P
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2000, 82B (01): : 138 - 141
  • [37] High-level production of recombinant human parathyroid hormone 1-34
    Suzuki, Y
    Yabuta, M
    Ohsuye, K
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1998, 64 (02) : 526 - 529
  • [38] Octreotide increases bone mineral density in a patient with carcinoid and osteoporosis.
    McCommon, D
    Tauer, K
    Palmieri, GM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S380 - S380
  • [39] Early response of bone turnover markers and bone mineral density to teriparatide [recombinant human parathyroid hormone (1-34)], in postmenopausal women previously treated with an antiresorptive drug.
    Ettinger, B
    San Martin, JA
    Crans, G
    Pavo, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S157 - S157
  • [40] A randomized controlled clinical trial to compare the efficacy of LY333334 [recombinant human parathyroid hormone (1-34)] and alendronate sodium in postmenopausal women with osteoporosis.
    Body, JJ
    Gaich, GA
    Scheele, WH
    Miller, PD
    Kulkarni, PM
    Hodsman, AB
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S179 - S179
12345